Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Acadia Healthcare Company Inc (ACHC) vs Freeport-McMoRan Inc (FCX) Price & Performance

Acadia Healthcare Company Inc
Freeport-McMoRan Inc

Price performance

Price movement over the last 24 hours

Key statistics

Acadia Healthcare Company Inc vs Freeport-McMoRan Inc — how do they compare? Acadia Healthcare Company Inc trades at $30.67 (market cap $2.94B), while Freeport-McMoRan Inc trades at $57.65 (market cap $85.29B). The key difference: Freeport-McMoRan Inc is far larger — about 29× Acadia Healthcare Company Inc's market cap, and Freeport-McMoRan Inc pays a 1.01% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.

ACHCFCX
Market Cap
$2.94B$85.29B
Sector
HealthBasic Materials
52-Week High
$31.92$71.73
52-Week Low
$11.68$35.34
Enterprise Value
$5.45B$91.95B
Dividend Yield
1.01%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Acadia Healthcare Company Inc

ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.

The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.

Freeport-McMoRan Inc

FCX trades at $59.27, down 2.77% on the day, with a bearish technical signal but strong fundamentals including a 10.34% net income margin and consistent earnings beats. Recent news highlights copper demand growth from AI and energy transitions, positioning FCX as a key player. Cash flow trends show improving operational performance, though net cash flow remains negative due to heavy investments.

Outlook is positive with a consensus price target of $71.81, implying 21% upside, supported by robust copper demand and expansion projects. Risks include commodity price volatility and execution challenges. Analyst sentiment is bullish with 59% buy ratings, but investors should monitor debt levels and global economic conditions.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Acadia Healthcare Company Inc

Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.

Read more on ACHC

About Freeport-McMoRan Inc

Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia

Read more on FCX